Dendreon Supporters take out Washington Post Ad

Now this is an interesting development from the Dendreon support camp.

Usually activist shareholders target an actual company for change to
enhance share prices, but a group of shareholders, patients, advocates, and
activists have a made an unusual move. In Sunday's Washington Post, this
group took out an advertisement calling for citizens to contact their
Congressional representatives to urge the FDA to reverse their delay of
Provenge.

This drug is a big deal for these people because Provenge is one of the few drugs that will combat late stage Prostate Cancer. It is a drug that could potentially keep a guy alive for another few months so people are going to be passionate about it.

A few months doesn't seem like much to some people but it is enough to gather your family members together for a nice sendoff. And to these people the FDA is standing in the way waiting by waiting 2 or 3 years for more data. I think I'll e-mail my Congressman like the ad says to do.